期刊文献+

miR-19a对非小细胞肺癌细胞组织因子的调控作用及细胞增殖的影响 被引量:1

The regulation ef ects of miR-19a on expression of tissue factor and the cell proliferation of NSCLC cells
原文传递
导出
摘要 目的 :探讨微小RNA(microRNA,miRNA,miR)-19a对非小细胞肺癌(non-small cell lung cancer,NSCLC)PC9细胞组织因子(tissue factor,TF)的调控作用及细胞增殖的影响。方法 :将hsa-miR-19a模拟物(hsa-miR-19a-mimic)、hsa-miR-19a抑制物(hsa-miR-19a-inhibitor)、hsa-miR阴性对照(hsa-miR-negative control,hsa-miR-NC)分别瞬时转染PC9细胞后,应用实时荧光定量PCR法检测各组细胞中miR-19a的表达,CCK-8(cell counting kit-8)法检测细胞的增殖情况,FCM法检测细胞周期的变化。利用生物信息学软件预测miR-19a的靶基因,通过荧光素酶报告基因检测系统和蛋白质印迹法对预测的潜在靶基因进行验证。结果 :Hsa-miR-19a-mimic转染组PC9细胞中miR-19a的表达水平明显高于空白对照组(只加脂质体)和阴性对照组(P<0.01),而hsa-miR-19a-inhibitor转染组PC9细胞中miR-19a的表达水平明显低于空白对照组和阴性对照组(P<0.05)。转染hsa-miR-19a-mimic可抑制PC9细胞的增殖,而转染hsa-miR-19a-inhibitor可促进PC9细胞的增殖(P<0.05)。Hsa-miR-19a-mimic转染组PC9细胞被阻滞于G0/G1期,而hsa-miR-19ainhibitor转染组G2/M期细胞所占比例增加(P<0.01)。荧光素酶报告基因检测提示,TF基因受miR-19a负调控。Hsa-miR-19a-mimic转染组TF蛋白的表达水平低于空白对照组和阴性对照组,hsa-miR-19a-inhibitor转染组则相反(P<0.01)。结论 :miR-19a可以调控TF的表达并抑制PC9细胞的体外增殖。 Objective: To investigate the regulation effects of microRNA (miRNA, miR)-19a on expression of tissue factor (TF) and the cell proliferation of non-small cell lung cancer (NSCLC) PC9 cells. Methods: The hsa-miR-1 9a-mimic, hsa-miR-19a-inhibitor and hsa-miR-negative control (hsa-miR-NC) were transiently transfected into PC9 cells, respectively. Then the expression of miR-1 9a was determined by real-time fluorescence quantitative-PCR. The proliferation of PC9 cells transfected with hsa-miR-1 9a- mimic, hsa-miR-19a-inhibitor or hsa-miR-NC was detected by cell counting kit-8 (CCK-8) assay. The cell cycle distribution was analyzed by flow cytometry (FCM). Bioinformatics software was used to predict downstream target genes of miR-19a. The potential target genes were verified by luciferase reporter assay and Western blotting. Results: The expression level of miR-19a in hsa-miR-19a-mimic-transfected group was higher than those in the blank control group (only adding liposomes) and the negative control group (P 〈 0.01), while the expression level of miR-19a in hsa-miR-19a-inhibitor-transfected group was opposite (P 〈 0.05). Hsa-miR-19a-mimic inhibited the proliferation of PC9 cells, while hsa-miR- 19a-inhibitor was opposite (P 〈 0.05). The cell cycle of PC9 cells was arrested at G0/G1 phase in hsa- miR-19a-mimic-transfected group, and the proportion of cells in G2/M phase in hsa-miR-19a-inhibitor- transfected group was increased (P 〈 0.01). The result of luciferase reporter assay revealed that miR- 19a negatively regulated the expression of TF gene. The expression level of TF protein in hsa-miR-19a-mimic-transfected group was lower than that in the blank control group or the negative control group, whereas the expression level of TF protein in hsa-miR-19a- inhibitor-transfected group was opposite (P 〈 0.01). Conclusion: The miR-19a can regulate the expression of TF and inhibit the proliferation of PC9 cells in vitro.
出处 《肿瘤》 CAS CSCD 北大核心 2014年第9期803-810,共8页 Tumor
关键词 非小细胞肺 微RNAS 凝血致活酶 细胞增殖 细胞周期 Carcinoma, non-small cell lung MicroRNAs Thromboplastin Cell Proliferation Cell cycle
  • 相关文献

参考文献38

  • 1陈万青,张思维,郑荣寿,曾红梅,邹小农,赵平,吴良有,李光琳,赫捷.中国2009年恶性肿瘤发病和死亡分析[J].中国肿瘤,2013,22(1):2-12. 被引量:448
  • 2Jemal A, Bray F,Center MM, et al. Global cancerstatistics[J]. CA Cancer J Clin,2011,61(2):69-90.
  • 3Herbst RS, Heymach JV, Lippman SM.Lung cancer[J]. N Engl J Med, 2008,359(13):1367-1380.
  • 4Rykov SV, Khodyrev DS, Pronina IV,et al. NovelmiRNA genes methylated in lung tumors[J].Cenettka,2013,49(7):896-901.
  • 5Khorana AA, Ahrendt SA, Ryan CK, et al. Tissuefactor expression, angiogenesis, and thrombosisin pancreatic cancer[J]. CHn Cancer Res,2007,13(10):2870-2875.
  • 6Uno K, Homma S, Satoh T, et al. Tissue factorexpression as a possible determinant ofthromboembolism in ovarian cancer[J]. Br J Cancer,2007,96(2):290-295.
  • 7Rauch U, Antoniak S, Boots M, et al. Associationof tissue-factor upregulation in squamous-cell carcinoma of the lung with increased tissuefactor in circulating blood[J]. Lancet Oncol,2005,6(4):254.
  • 8Del Conde I,Bharwani LD, Dietzen DJ, et al.Microvesicle-associated tissue factor and Trousseau's syndrome[J]. J Thromb Haemost,2007,5(1):70-74.
  • 9Sato T, Tsujino I, Ikeda D, et al. Trousseau’ssyndrome associated with tissue factor producedby pulmonary adenocarcinoma[J]. Thorax,2006,61(11):1009-1010.
  • 10Amirkhosravi A, Meyer T,Chang JY, et al. Tissuefactor pathway inhibitor reduces experimentallung metastasis of B16 melanoma[J].Thromb Haemostt 2002,87(6):930-936.

二级参考文献17

  • 1KLEBR S, SANCHO-MARTINEZ I, WlESTLER B, et al. Yes and PI3K bind CD95 to signal invasion of glioblastoma[J]. Cancer Cell, 2008, 13(3):235-248.
  • 2LEWIS B P, BURGE C B, BARTEL D P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets[J]. Cell, 2005, 120(1 ):15-20.
  • 3XlA H, NG S S, JIANG S, et al. MiR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion[J]. Biochem Biophys Res Cornmun, 2010, 391(1):535-541.
  • 4WU Q, GUO R, LIN M, et al. MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2[J]. Gynecol Oncol, 2011, 122(1 ):149-154.
  • 5HUNG C S, LIU H H, LIU J J, et al. MicroRNA-200a and -200b mediated hepatocellular carcinoma cell migration through the epithelial to mesenchymal transition markers[J]. Ann Surg Oncol, 2012[Epub ahead of print].
  • 6COCHRANE D R, SPOELSTR N S, HOWE E N, et al. MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents[J]. Mol Cancer Ther, 2009, 8(5):1055-1066.
  • 7KORPAL M, LEE E S, HU G, et al. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2[J].J Biol Chem 2008, 283(22):14910-14914.
  • 8HURTEAU G J, CARLSON J A, ROOS E, et al. Stable expression of miR-200c alone is sufficient to regulate TCF8 (ZEB1) and restore E-cadherin expression[J]. Cell Cycle, 2009, 8:2064-2069.
  • 9ORIDIS C, BRUNET J F. NCAM: structural diversity, function and regulation of expression[J]. Sernin CellBiol, 1 992, 3(3):189-1 97.
  • 10SASAKI H, YOSHIDA K, IKEDA E, eta/. Expression of the neural cell adhesion molecule in astrocytic tumors: an inverse correlation with malignancy[J]. Cancer, 1998, 82(10):1921-1931.

共引文献454

同被引文献18

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部